Wearable patches can be attached to the skin or can be worn for few hours to a couple of weeks. These patches are becoming popular and can be used for drug delivery, patient monitoring, and diagnosing purpose. These patches are also been used for the treatment and delivery of medication such as nicotine patch in Nicotine Replacement Therapy (NRT) and anti-aging patches. The connected wearable patches feature wireless connectivity in addition to the features of regular wearable patches that help in monitoring the health of an individual and delivering drugs accordingly. Features such as continuous monitoring of patients body activity coupled with precise data, minimal interference with body movements and easy connectivity with the various smartphones are some of the pivotal factors that are expected to drive growth of the market.
Market Dynamics
Increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market are expected to propel the market growth over the forecast period. For instance, in June 2018, LifeSignals, Inc. entered into a collaboration with INQCEL, a California-based physical and virtual innovation lab and Dreamtech, a contract manufacturing organization, to receive support for development and manufacturing of new biosensor wearable based on the Lifesignal Processor (LSP). Under this collaboration, Dreamtech provides LSP-centric design and contract manufacturing services, and INQCEL provides services and application-based support tools to develop clinical and consumer grade wearable patch.
Key features of the study:
- This report provides in-depth analysis of the global wearable patch market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global wearable patch market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Medtronic Plc, Hill-Rom Holdings, Inc. (Welch Allyn), iRhythm Technologies, Inc., AliveCor, Inc., Vivalnk, Inc., Cardiac Insight Inc., VitalConnect, LifeSignals, Inc., L’oreal Group, Dexcom, Inc., GENTAG, Inc., Abbott Laboratories, and Koninklijke Philips N.V.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global wearable patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wearable patch market
Detailed Segmentation:
- Global Wearable Patch Market, By Technology:
- Global Wearable Patch Market, By Application:
- Monitoring
- Drug Delivery
- Diagnostics
- Global Wearable Patch Market, By End User:
- Healthcare
- Fitness & Sports
- Global Wearable Patch Market, By Region:
- North America
- By Technology:
- By Application:
- Monitoring
- Drug Delivery
- Diagnostics
- By End User:
- Healthcare
- Fitness & Sports
- By Country:
- Latin America
- By Technology:
- By Application:
- Monitoring
- Drug Delivery
- Diagnostics
- By End User:
- Healthcare
- Fitness & Sports
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Technology:
- By Application:
- Monitoring
- Drug Delivery
- Diagnostics
- By End User:
- Healthcare
- Fitness & Sports
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Technology:
- By Application:
- Monitoring
- Drug Delivery
- Diagnostics
- By End User:
- Healthcare
- Fitness & Sports
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Technology:
- By Application:
- Monitoring
- Drug Delivery
- Diagnostics
- By End User:
- Healthcare
- Fitness & Sports
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Technology:
- By Application:
- Monitoring
- Drug Delivery
- Diagnostics
- By End User:
- Healthcare
- Fitness & Sports
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Medtronic Plc *
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Hill-Rom Holdings, Inc. (Welch Allyn)
- iRhythm Technologies, Inc.
- AliveCor, Inc.
- Vivalnk, Inc.
- Cardiac Insight Inc.
- VitalConnect
- LifeSignals, Inc.
- L’oreal Group
- Dexcom, Inc.
- GENTAG, Inc.
- Abbott Laboratories
- Koninklijke Philips N.V.
“*” marked represents similar segmentation in other categories in the respective section.